# MAGNACHIP SEMICONDUCTOR Corp: overview

MX · NYSE · CIK 1325702 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mx.md) · [Financials](/companies/mx/financials.md) · [Filings](/companies/mx/filings.md) · [Insiders](/companies/mx/insiders.md)

Latest reported revenue: [$44.7m](/filings/0001193125-26-342416.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-342416).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [55.4](/filings/0001193125-25-274333.md) | [51.2 d](/filings/0001193125-26-108435.md) | [44.7](/filings/0001193125-26-214750.md) | [47.6](/filings/0001193125-26-342416.md) | [45.9](/filings/0001193125-25-274333.md) | [40.6 d](/filings/0001193125-26-108435.md) | [46.2](/filings/0001193125-26-214750.md) | [44.7](/filings/0001193125-26-342416.md) |
| Gross margin | % | [20.8%](/filings/0001193125-25-274333.md) | [21.7% d](/filings/0001193125-26-108435.md) | [20.9%](/filings/0001193125-26-214750.md) | [20.4%](/filings/0001193125-26-342416.md) | [18.6%](/filings/0001193125-25-274333.md) | [9.3% d](/filings/0001193125-26-108435.md) | [15.6%](/filings/0001193125-26-214750.md) | [19.3%](/filings/0001193125-26-342416.md) |
| Operating margin | % | [(8.1%)](/filings/0001193125-25-274333.md) | [(13.3%) d](/filings/0001193125-26-108435.md) | [(11.8%)](/filings/0001193125-26-214750.md) | [(13.9%)](/filings/0001193125-26-342416.md) | [(25.1%)](/filings/0001193125-25-274333.md) | [(30.7%) d](/filings/0001193125-26-108435.md) | [(15.5%)](/filings/0001193125-26-214750.md) | [(22.3%)](/filings/0001193125-26-342416.md) |
| Net margin | % | [(17.3%)](/filings/0001193125-25-274333.md) | [(31.8%) d](/filings/0001193125-26-108435.md) | [(19.9%)](/filings/0001193125-26-214750.md) | [0.7%](/filings/0001193125-26-342416.md) | [(28.5%)](/filings/0001193125-25-274333.md) | [(19.9%) d](/filings/0001193125-26-108435.md) | [(10.1%)](/filings/0001193125-26-214750.md) | [(10.8%)](/filings/0001193125-26-342416.md) |
| Diluted EPS | $ per share | [(0.26)](/filings/0001193125-25-274333.md) | not reported | [(0.24)](/filings/0001193125-26-214750.md) | [0.01](/filings/0001193125-26-342416.md) | [(0.36)](/filings/0001193125-25-274333.md) | not reported | [(0.13)](/filings/0001193125-26-214750.md) | [(0.13)](/filings/0001193125-26-342416.md) |
| Free cash flow | $m | [(15.5) d](/filings/0001193125-25-274333.md) | [4.4 d](/filings/0001193125-26-108435.md) | [(0.0)](/filings/0001193125-26-214750.md) | [(0.0) d](/filings/0001193125-26-342416.md) | [(49.3) d](/filings/0001193125-25-274333.md) | [(4.8) d](/filings/0001193125-26-108435.md) | [(0.0)](/filings/0001193125-26-214750.md) | [(0.0) d](/filings/0001193125-26-342416.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [474](/filings/0001193125-24-063674.md) | [338](/filings/0001193125-24-063674.md) | [230](/filings/0001193125-25-054851.md) | [196](/filings/0001193125-26-108435.md) | [179](/filings/0001193125-26-108435.md) |
| Gross margin | % | [32.4%](/filings/0001193125-24-063674.md) | [30.0%](/filings/0001193125-24-063674.md) | [22.4%](/filings/0001193125-25-054851.md) | [19.7%](/filings/0001193125-26-108435.md) | [17.6%](/filings/0001193125-26-108435.md) |
| Operating margin | % | [17.6%](/filings/0001193125-24-063674.md) | [(1.6%)](/filings/0001193125-24-063674.md) | [(25.1%)](/filings/0001193125-25-054851.md) | [(13.2%)](/filings/0001193125-26-108435.md) | [(20.0%)](/filings/0001193125-26-108435.md) |
| Net margin | % | [12.0%](/filings/0001193125-24-063674.md) | [(2.4%)](/filings/0001193125-24-063674.md) | [(15.9%)](/filings/0001193125-25-054851.md) | [(27.6%)](/filings/0001193125-26-108435.md) | [(16.6%)](/filings/0001193125-26-108435.md) |
| Diluted EPS | $ per share | [1.21](/filings/0001193125-24-063674.md) | [(0.18)](/filings/0001193125-24-063674.md) | [(0.89)](/filings/0001193125-25-054851.md) | [(1.44)](/filings/0001193125-26-108435.md) | [(0.82)](/filings/0001193125-26-108435.md) |
| Free cash flow | $m | [55.5](/filings/0001193125-24-063674.md) | [(18.2)](/filings/0001193125-24-063674.md) | [(10.0)](/filings/0001193125-25-054851.md) | [(17.7)](/filings/0001193125-26-108435.md) | [(54.2)](/filings/0001193125-26-108435.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mx/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $7.6m | 1,615,488 |  | Added +370,866 |
| [FourWorld Capital Management LLC](/funds/1770525.md) | 2026-06-30 | $7.6m | 1,600,695 |  | Reduced −57,006 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $7.1m | 1,501,438 |  | Added +929,604 |
| [OAKTREE CAPITAL MANAGEMENT LP](/funds/949509.md) | 2026-06-30 | $7.1m | 1,500,000 |  | Reduced −1,349,858 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $6.6m | 1,397,759 |  | Added +1,238,153 |
| [OAKTREE CAPITAL MANAGEMENT LP](/funds/949509.md) | 2026-06-30 | $4.7m | 1,000,000 | Call | New +1,000,000 |
| [NOMURA HOLDINGS INC](/funds/1163653.md) | 2026-06-30 | $4.7m | 1,000,000 | Call | New +1,000,000 |
| [Caption Management, LLC](/funds/1706766.md) | 2026-06-30 | $4.7m | 1,000,000 | Put | New +1,000,000 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $3.1m | 661,600 |  | Added +626,100 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $2.6m | 544,125 |  | Reduced −166,319 |

## Recent filings

[All 914 filings](/companies/mx/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-21 | 11:05 ET | [8-K](/filings/0001193125-26-396059.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-396059 |
| 2026-08-10 | 20:15 ET | [10-Q](/filings/0001193125-26-342416.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342416 |
| 2026-07-29 | 20:30 ET | [8-K](/filings/0001193125-26-323843.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-323843 |
| 2026-06-30 | 10:10 ET | [8-K](/filings/0001193125-26-289285.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-289285 |
| 2026-06-17 | 21:02 ET | [8-K](/filings/0001193125-26-274356.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-274356 |
| 2026-06-17 | 10:30 ET | [8-K](/filings/0001193125-26-273349.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-273349 |
| 2026-05-08 | 20:30 ET | [10-Q](/filings/0001193125-26-214750.md) | Quarterly report, period 2026-03-31 | 0001193125-26-214750 |
| 2026-04-30 | 20:30 ET | [DEF 14A](/filings/0001193125-26-197484.md) | Proxy statement, period 2026-06-11 | 0001193125-26-197484 |
| 2026-04-28 | 20:30 ET | [8-K](/filings/0001193125-26-187239.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-187239 |
| 2026-03-16 | 20:30 ET | [10-K](/filings/0001193125-26-108435.md) | Annual report, period 2025-12-31 | 0001193125-26-108435 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-108435.md), filed Mar 16, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/42ed4749-aa53-4c27-9c8c-9b0bcf544bda)

## About the filer

- CIK: 1325702
- Tickers: MX
- Exchange: NYSE
- SIC code: 3674 Semiconductors & Related Devices
- State of incorporation: DE
- Filer category: Accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.